Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MURALIKRISHNA V CHELIKANI

Allopathic & Osteopathic Physicians Internal Medicine Critical Care Medicine

NPI
1083814545
CMS profile
1191217
Location
HOUSTON, TX

General Payments · PY2018–2024

$3,546.73

  • Reported across 150 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$277.82

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $277.82 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $73.04 3
Insmed, Inc. $49.48 2
ResMed Corp $43.49 2
Pulmonx Corporation $37.50 2
GlaxoSmithKline, LLC. $36.01 2
Teleflex LLC $20.82 1
Takeda Pharmaceuticals U.S.A., Inc. $17.48 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $483.15 30
PY2019 $1,474.19 37
PY2020 $212.97 12
PY2021 $151.09 9
PY2022 $549.19 28
PY2023 $398.32 21
PY2024 $277.82 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.21 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104464016 CMS
AstraZeneca Pharmaceuticals LP $29.67 06/06/2024 Food and Beverage Undisputed 01/23/2026 1105674725 CMS
AstraZeneca Pharmaceuticals LP $20.16 06/24/2024 Food and Beverage Undisputed 01/23/2026 1104239717 CMS
GlaxoSmithKline, LLC. $18.93 02/16/2024 Food and Beverage Undisputed 01/23/2026 1116663105 CMS
GlaxoSmithKline, LLC. $17.08 03/12/2024 Food and Beverage Undisputed 01/23/2026 1116296049 CMS
Insmed, Inc. $24.14 05/23/2024 Food and Beverage Undisputed 01/23/2026 1089577460 CMS
Insmed, Inc. $25.34 10/30/2024 Food and Beverage Undisputed 01/23/2026 1089561484 CMS
Pulmonx Corporation $22.49 04/11/2024 Food and Beverage Undisputed 01/23/2026 1087846456 CMS
Pulmonx Corporation $15.01 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087846458 CMS
Resmed Corp $18.83 03/21/2024 Food and Beverage Undisputed 01/23/2026 1140205575 CMS
Resmed Corp $24.66 10/11/2024 Food and Beverage Undisputed 01/23/2026 1140205573 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.48 06/04/2024 Food and Beverage Undisputed 01/23/2026 1137509006 CMS
Teleflex LLC $20.82 04/10/2024 Food and Beverage Undisputed 01/23/2026 1142098457 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.